Pfizer Inc.’s request to expand use of its COVID-19 vaccine in adolescents will spur consideration by a US Centers for Disease Control and Prevention panel on how it should be administered relative to other inoculations on the adolescent immunization schedule.
On 9 April, Pfizer and partner BioNTech SE requested the US Food and Drug Administration amend the emergency use...







